SequelSEC

Merck & Co., Inc. MRK

Pharmaceutical Preparations · CIK 0000310158 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$66.57B
Fiscal year ended 2026-06-30
Operating income
Unavailable
Fiscal year ended 2026-06-30
Free cash flow
$16.06B
Fiscal year ended 2026-06-30

Merck & Co., Inc. (MRK) reported revenue of $66.57B and net income of $3.17B for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Merck & Co., Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Merck & Co., Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$66.57B
Cost of revenue$18.00B
Gross profit$48.57B
Operating incomeUnavailable
Net income$3.17B
Research & development$30.45B
Weighted-average diluted sharesUnavailable
Pretax income$5.95B
Income tax expense$2.78B
Diluted EPSUnavailable
Selling, general & administrative$11.14B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

Merck & Co., Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$6.85B
Total assets$129.80B
Current assets$36.68B
Total liabilitiesUnavailable
Current liabilities$27.73B
Total equity incl. NCI$41.98B
Temporary (mezzanine) equityUnavailable
Inventory$6.21B
Accounts receivable$12.56B
Goodwill$21.58B
Long-term debt$51.08B
Accounts payable$3.83B

Cash flow

Merck & Co., Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$19.97B
Capital expenditures$3.90B
Investing cash flow-$27.30B
Financing cash flow$6.17B
Net change in cash-$1.18B
Stock-based compensation$892.00M
Common dividends paid$8.30B
Common share repurchases$4.21B
Depreciation & amortizationUnavailable

Derived

Merck & Co., Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$16.06B
Gross margin73.0%
Operating marginUnavailable
FCF margin24.1%
SBC / revenue1.3%
Current ratio1.32x
Revenue YoY growth4.6%
Net margin4.8%
R&D / revenue45.7%
CapEx / revenue5.9%
Long-term debt / equity1.22x
Effective tax rate46.7%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MRK in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-04View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-02View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.